ArticlePatient preference and adherence2011

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

Bradley J RobottomPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.